Results for tag: "Polyunsaturated Fatty Acids"

In biotechnology, the Polyunsaturated Fatty Acids (PUFA) market encompasses the development, production, and sale of fatty acids which contain multiple double bonds between the atoms in their hydrocarbon chains. These fats are essential in human nutrition and are known for their health benefits, including a role in reducing the risk of heart disease and supporting brain function. Biotechnological innovations in this market involve the bioengineering of microorganisms and plants to increase the efficiency and scale of PUFA production, thus enabling a sustainable and consistent supply of these nutrients. Advanced genetic engineering and fermentation processes are applied to synthesize fatty acids such as omega-3 and omega-6, which cannot be adequately produced by the human body. Additionally, biotechnology aids in the development of PUFA-enriched functional foods, supplements, and pharmaceuticals, catering to the dietary needs and health consciousness of consumers. Prominent companies actively engaged in the PUFA market within biotechnology include BASF SE, which focuses on the nutrition & health sector; DSM, renowned for its life sciences and material sciences; Cargill, incorporating biotech in agriculture and food; and the biotech firm Evonik Industries, which specializes in chemicals. These companies are key players in advancing PUFA-related biotechnological research, production, and commercialization, striving to meet the nutritional needs of a diverse consumer base. Show Less Read more